Boehncke, Wolf-Henning

 
 
Show items per page
Elements: 325
Page 1 on 7

2021

Scientific Articles

add to browser selection
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trialBottomley, Andrew; Coens, Corneel; Mierzynska, Justyna; Blank, Christian U; ... Boehncke, Wolf-Henning
add to browser selection
Association of sex and systemic therapy treatment outcomes in psoriasis: a two-country, multicentre, prospective, noninterventional registry studyMaul, J-T; Augustin, M; Sorbe, C; Conrad, C; ... Navarini, A A
add to browser selection
Circadian clocks guide dendritic cells into skin lymphaticsHoltkamp, Stephan J.; Ince, Louise; Barnoud, Coline; Schmitt, Madeleine T.; ... Scheiermann, Christoph
add to browser selection
Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysisMease, Philip J; McInnes, Iain B; Tam, Lai-Shan; Eaton, Kiefer; ... Ritchlin, Christopher
add to browser selection
Dermatologie: Passage de la dermatite atopique au psoriasis - et retourBoehncke, Wolf-Henning; Stalder Monney, Romaine; Brembilla, Nicolo;
add to browser selection
Deutsche S3-Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm – Teil 1: Therapieziele und TherapieempfehlungenNast, Alexander; Altenburg, Andreas; Augustin, Matthias; Boehncke, Wolf-Henning; ... Dressler, Corinna
add to browser selection
Deutsche S3-Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm – Teil 2: Therapiemonitoring, besondere klinische Situationen und KomorbiditätNast, Alexander; Altenburg, Andreas; Augustin, Matthias; Boehncke, Wolf-Henning; ... Dressler, Corinna
add to browser selection
Dysfunctional keratinocytes increase dermal inflammation in systemic sclerosis. Results from tissue-engineered scleroderma epidermisRusso, Barbara; Borowczyk, Julia; Boehncke, Wolf-Henning; Truchetet, Marie-Elise; ... Chizzolini, Carlo
add to browser selection
German S3-Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm - Part 1: Treatment goals and treatment recommendationsNast, Alexander; Altenburg, Andreas; Augustin, Matthias; Boehncke, Wolf-Henning; ... Dressler, Corinna
add to browser selection
German S3-Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm - Part 2: Treatment monitoring and specific clinical or comorbid situationsNast, Alexander; Altenburg, Andreas; Augustin, Matthias; Boehncke, Wolf-Henning; ... Dressler, Corinna
add to browser selection
Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experiencedRitchlin, Christopher T; Helliwell, Philip S; Boehncke, Wolf-Henning; Soriano, Enrique R; ... Deodhar, Atul
add to browser selection
IL-25 (IL-17E) in epithelial immunology and pathophysiologyBorowczyk, Julia; Shutova, Maria; Brembilla, Nicolo; Boehncke, Wolf-Henning;
add to browser selection
Interleukin-17E, inducible nitric oxide synthase and arginase1 as new biomarkers in the identification of neutrophilic dermatosesStalder, Romaine; Brembilla, Nicolo; Conrad, C; Yawalkar, Nikhil; ... Kaya, Guerkan
add to browser selection
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statementNash, Peter; Kerschbaumer, Andreas; Dörner, Thomas; Dougados, Maxime; ... Smolen, Josef S
add to browser selection
Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic ArthritisRahman, Proton; Ritchlin, Christopher T; Helliwell, Philip S; Boehncke, Wolf-Henning; ... McInnes, Iain B
add to browser selection
Psoriasisarthritis : Wichtige Aspekte für die PraxisBoehncke, Wolf-Henning;
add to browser selection
Psoriasisarthritis: Relevantes für die dermatologische PraxisBoehncke, Wolf-Henning;
add to browser selection
Psoriasis : pourquoi en parler encore et toujours ?Boehncke, Wolf-Henning; Gilliet, Michel;
add to browser selection
Voneinander lernen, miteinander behandelnBoehncke, Wolf-Henning; Ehrchen, Jan; Mrowietz, Ulrich;

2020

Scientific Articles

add to browser selection
Association between clinical specialty setting and disease management in patients with psoriatic arthritis: results from LOOP, a cross-sectional, multi-country, observational studyBoehncke, Wolf-Henning; Horváth, R; Dalkiliç, E; Lima, S A L; ... Lubrano, E
add to browser selection
Cytokines of the IL-17 family in psoriasisLauffer, Felix; Eyerich, Kilian; Boehncke, Wolf-Henning; Asadullah, Khusru; ... Schön, Michael P
add to browser selection
Disease burden and treatment needs of patients with psoriasis in sexually-sensitive and visible body areas: results from a large-scale survey in routine careda Silva, Neuza; Augustin, Matthias; Langenbruch, Anna; Mrowietz, Ulrich; ... Sommer, Rachel
add to browser selection
Disease Characteristics and the Burden of Joint and Skin Involvement Amongst People With Psoriatic Arthritis: A Population SurveyTillett, William; Merola, Joseph F; Thaçi, Diamant; Holdsworth, Elizabeth; ... Boehncke, Wolf-Henning
add to browser selection
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 updateGossec, Laure; Baraliakos, Xenofon; Kerschbaumer, Andreas; de Wit, Maarten; ... Smolen, Josef S
add to browser selection
GRAPPA Trainees Symposium 2019: A Report from the GRAPPA 2019 Annual MeetingHughes, Catherine D; van Mens, Leonieke J J; Boehncke, Wolf-Henning; Ritchlin, Christopher T;
add to browser selection
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trialDeodhar, Atul; Helliwell, Philip S; Boehncke, Wolf-Henning; Kollmeier, Alexa P; ... Ritchlin, Christopher T
add to browser selection
IL-17A in psoriasis and beyond: cardiovascular and metabolic implicationsvon Stebut, Esther; Boehncke, Wolf-Henning; Ghoreschi, Kamran; Gori, Tommaso; ... Schäffler, Andreas
add to browser selection
IL-17E (IL-25) and IL-17A differentially affect the functions of human keratinocytesBorowczyk, Julia; Buerger, Claudia; Tadjrischi, Neschaat; Drukala, Justyna; ... Brembilla, Nicolo
add to browser selection
Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase ii studyMease, Philip J; Gladman, Dafna D; Deodhar, Atul; McGonagle, Dennis G; ... Helliwell, Philip S
add to browser selection
Les cytokines IL-17, une famille en expansion utilisée comme cible pour des thérapies anti-inflammatoires innovantesBoehncke, Wolf-Henning; Stalder Monney, Romaine; Brembilla, Nicolo Costantino;
add to browser selection
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature researchKerschbaumer, Andreas; Smolen, Josef S; Nash, Peter; Doerner, Thomas; ... van der Heijde, Desirée
add to browser selection
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of ExposureArmstrong, April; Paul, Carle; Puig, Luis; Boehncke, Wolf-Henning; ... Lebwohl, Mark G
add to browser selection
Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred careda Silva, Neuza; Augustin, Matthias; Langenbruch, Anna; Mrowietz, Ulrich; ... Sommer, Rachel
add to browser selection
Targeted cutaneous delivery of etanercept using Er:YAG fractional laser ablationDel Río-Sancho, Sergio; Lapteva, Maria; Sonaje, Kiran; Böhler, Christof; ... Kalia, Yogeshvar
add to browser selection
The Janus Kinase inhibitor tofacitinib impacts human dendritic cell differentiation and favours M1 macrophage developmentStalder Monney, Romaine; Zhang, Bin; Wrobel, Ludovic; Boehncke, Wolf-Henning; Brembilla, Nicolo
add to browser selection
Tofacitinib in psoriatic arthritis patients: skin signs and symptoms and health-related quality of life from two randomized phase 3 studiesMerola, J F; Papp, K A; Nash, P; Gratacós, J; ... Young, P
add to browser selection
Traitement des kératoses actiniques : l'embarras du choixMuhlstadt, Michaël; Tzika, Evangelia; Boehncke, Wolf-Henning;
add to browser selection
Zytokine der IL-17-Familie bei der PsoriasisLauffer, Felix; Eyerich, Kilian; Boehncke, Wolf-Henning; Asadullah, Khusru; ... Schön, Michael P

Thesis supervisions

add to browser selection
Role of the crosstalk between epithelial and mesenchymal cells in fibrotic disorders focusing on IL-25 within systemic sclerosisRusso, Barbara;

2019

Scientific Articles

add to browser selection
Autoreactive T-Lymphocytes in Inflammatory Skin DiseasesBoehncke, Wolf-Henning; Brembilla, Nicolo;
add to browser selection
Best-practice Indicators in Psoriatic Disease CareHelliwell, Philip S; Favier, Guillaume; Gladman, Dafna D; Soriano, Enrique R; ... Thaçi, Diamant
add to browser selection
Cardiovascular Diseases in Psoriasis and Psoriatic ArthritisEder, Lihi; Dey, Amit; Joshi, Aditya A; Boehncke, Wolf-Henning; ... Szentpetery, Agnes
add to browser selection
Cave linguam – ce qu'on dit (ou écrit) et ce que le public entend…Boehncke, Wolf-Henning;
add to browser selection
Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase 2 TrialHelliwell, Phillip S; Deodhar, Atul; Gottlieb, Alice B; Boehncke, Wolf-Henning; ... Ritchlin, Christopher T
add to browser selection
Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practiceMaul, Julia-Tatjana; Navarini, A A; Sommer, R; Anzengruber, F; ... Augustin, M
add to browser selection
Gene-diet interactions associated with complex trait variation in an advanced intercross outbred mouse lineVorobyev, Artem; Gupta, Yask; Sezin, Tanya; Koga, Hiroshi; ... Ludwig, Ralf J
add to browser selection
GRAPPA Trainees Symposium 2018: A Report from the GRAPPA 2018 Annual MeetingFord, Adam R; Mascia, Enrico; Boehncke, Wolf-Henning; Ritchlin, Christopher T;
add to browser selection
IL-17E (IL-25) Enhances Innate Immune Responses during Skin InflammationSenra, Luisa; Mylonas, Alessio; Kavanagh, Ruairi D; Fallon, Padraic G; ... Brembilla, Nicolo
add to browser selection
Interleukin-38 interacts with destrin/actin-depolymerizing factor in human keratinocytesTalabot Frischknecht-Ayer, Dominique; Mermoud, Loïc Xavier; Borowczyk, Julia; Drukala, Justyna; ... Palmer-Lourenco, Gaby
add to browser selection
Linkage between patients' characteristics and prescribed systemic treatments for psoriasis: a semantic connectivity map analysis of the Swiss Dermatology Network for Targeted Therapies registryCazzaniga, S; Anzengruber, F; Augustin, M; Boehncke, Wolf-Henning; ... Yawalkar, N
<< previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 |